Alnylam Pharmaceuticals, Inc. (ALNY)
156.60
+0.66
(+0.42%)
USD |
NASDAQ |
Nov 09, 16:00
156.60
0.00 (0.00%)
After-Hours: 17:30
Alnylam Pharmaceuticals Gross Profit (Annual) : 3.032B for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.032B |
| December 31, 2024 | 1.925B |
| December 31, 2023 | 1.518B |
| December 31, 2022 | 868.60M |
| December 31, 2021 | 704.14M |
| December 31, 2020 | 414.80M |
| December 31, 2019 | 194.69M |
| December 31, 2018 | 66.67M |
| December 31, 2017 | 76.54M |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 77.63M |
| December 31, 2010 | 95.10M |
| December 31, 2009 | 94.54M |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | 915.36M |
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Pfizer Inc. | 41.04B |
| BridgeBio Pharma, Inc. | 478.38M |
| Cerenome, Inc. | 4.768M |